Market Intelligence

Why BJs Rest BJRI deserves a spot in every portfolio Hovering 20260511 INVZ Innoviz reports 127 percent year over year revenue growth misses EPS targets as stock dips 149 percent SPAR Group SGRP Stock What Is Driving the Price Q4 2024 EPS Misses Views iShares Latin America 40 ETF ILF Hits AllTime High Amid Select Thematic ETF Outperformance in Volatile 2026 Markets KSPI Joint stock proves resilient despite 155 percent EPS miss as investors search for silver lining China Tech Regulatory and CrossBorder AI Investment Analysis Deere Company DE NearTerm Price Underperformance Amid Broader Market Gains Sets Up PreEarnings Opportunity What Madrigal Pharmaceuticals MDGL does that creates lasting value Risk Aversion 20260508 Eagle EICA Trading at 2492 Key Decision Point 20260518 Genuine GPC Drops 399 Key Support at 8864 20260515 The Illusion of Reciprocity Examining Potential Market Impacts of SelfDefeating Trade Policy US GROW Stock Analysis 344 Gain What to Watch 20260518 ARKO Q1 2026 Earnings Wide EPS Surprise Despite Negative Bottom Line Zebra ZBRA Reports Strong Q1 2026 Revenue NA EPS Beats JPMorgans Summer Reading List for Wealthy Clients Features AI and Leadership Themes Trump in Beijing USChina Economic Rivalry Takes Center Stage Singapore Regulator Targets Faster Private Banking Account Opening for Wealthy Clients Geopolitical Tensions Rise Fresh US Strikes Complicate Iran Nuclear Deal Negotiations Saudi Arabias Vision 2030 Spending Spree Hits Fiscal Constraints Waymo Expands Pause of Robotaxi Services to Five US Cities Following Flood Incidents PutinXi Talks Aim to Revive Stalled Power of Siberia 2 Pipeline Amid Iran Conflict Energy Uncertainty Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model PGR Q1 2026 Earnings Earnings Beat Estimate Despite Lack of Revenue Detail Stock Edges Up ArcelorMittal MT Q1 2026 Earnings Modest EPS Beat Amid Market Uncertainties Renasant Q1 2026 Earnings EPS Beats Estimates by 81 Amid Solid Performance CTNT Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Management Amidst Revenue Uncertainty RVSN Q3 2023 Earnings EPS Exceeds Estimates Despite Absence of Revenue Cytokinetics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Focus Intensifies Pagaya Technologies Warrants PGYWW Climb 1255 as LowPriced Warrants Test Key 006 Level LuxExperience LUXE Slides 14 as Selling Pressure Builds Near Support Newmark Group NMRK Edges Higher Amid Modest Gains Key Levels in Focus Kiora Pharmaceuticals KPRX Rallies 55 Key Levels to Watch After Recent Uptick Andretti Acquisition Corp II POLE Holds Steady Near Trust Value Amid Minimal Volatility